PGC-1β and ERRα promote glutamine metabolism and colorectal cancer survival via transcriptional regulation of PCK2
D. E. Frodyma, T. C. Troia, J. A. Berg, C. Rao, R. A. Svoboda, D. D. Shinde, V. C. Thomas, R. E. Lewis, K. W. Fisher
Abstract
Previous studies have shown that Peroxisome Proliferator-Activated Receptor Gamma, Coactivator 1 Beta (PGC-1{beta}) and Estrogen-Related Receptor Alpha (ERR) are over-expressed in colorectal cancer and promote tumor survival. In this study, we show that amino acid motif LRELL on PGC-1{beta} is responsible for the physical interaction with ERR and promotes ERR mRNA and protein expression. We used RNAsequencing to determine the genes regulated by both PGC-1{beta} & ERR and found that mitochondrial Phosphoenolpyruvate Carboxykinase 2 (PCK2) was the gene that decreased most significantly after depletion of both genes. Depletion of PCK2 in colorectal cancer cells was sufficient to reduce anchorage-independent growth and inhibit glutamine utilization by the TCA cycle. Lastly, shRNA-mediated depletion of ERR decreased anchorage-independent growth and glutamine metabolism, which could not be rescued by plasmid derived expression of PCK2. These findings suggest that transcriptional control of PCK2 is one mechanism used by PGC-1{beta} and ERR to promote glutamine metabolism and colorectal cancer cell survival.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells
K. Leithner, G. Grasmann, … H. Olschewski·bioRxiv·Nov 23, 2020
- p38α MAPK integrates opposing oncogenic APC/β-catenin/TCF and GUCY2C tumor-suppressor axes in colorectal cancer
Ariana A. Entezari, Adi Caspi, … Scott Arthur Waldman·bioRxiv·Oct 6, 2026
- Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
A. M. Strom, S. Chaurasiya, … J.-A. Gustafsson·bioRxiv·Nov 20, 2019
- T50 O-GlcNAc PKM2 promotes aerobic glycolysis and PDAC progression via ARNT-CDC27-AKT pathway
Bin Yang, Yi Zhu, … Shikai Zhu·bioRxiv·Jul 29, 2026
- Papillary renal cell carcinomas rewire glutathione metabolism and are deficient in anabolic glucose synthesis
A. Alahmad, V. Paffrath, … D. Meierhofer·bioRxiv·May 27, 2019
- TGF-B signaling suppresses TCA cycle metabolism in renal cancer.
H. Nam, A. Kundu, … S. Sudarshan·bioRxiv·Feb 19, 2021